ZIMV News and Press, ZimVie Inc. From 01/30/23

WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs have been implanted worldwide. This includes patients treated in over 25 countries since the fir...

WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California. Vafa Jamali, Preside...

Summary ZimVie Inc. was spun out of Zimmer Biomet in early March. After a stock plunge that has halved the stock's valuation, ZimVie once again screens attractive on both P/E and P/CF metrics. The September selloff appears to have been caused by Zimmer Biomet pledging its ZimV...

Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...

Image source: The Motley Fool. ZimVie Inc. (NASDAQ: ZIMV) Q3 2022 Earnings Call Nov 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ZimVie Inc. (ZIMV) Q3 2022 Earnings Call Transcript

ZimVie press release ( NASDAQ: ZIMV ): Q3 Non-GAAP EPS of $0.49. Revenue of $214.58M (-10.4% Y/Y). Adjusted EBITDA of $29.4 million; adjusted EBITDA margin of 13.8% Cash and cash equivalents of $116.0 million at September 30, 2022 For further details see...

Third party net sales of $213.3 million Net income of $0.8 million; net income margin of 0.4%; adjusted net income [1] of $12.9 million Diluted EPS of $0.03; adjusted diluted EPS [1] of $0.49 Adjusted EBITDA [1] of $29.4 millio...

WESTMINSTER, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX Implant in the United States, the latest innovation in the company’s platform of surgical, restorativ...

WESTMINSTER, Colo., Oct. 19, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the third quarter 2022 after market close on Wednesday, November 9, 2022. Company management will h...

WESTMINSTER, Colo., Oct. 11, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of the Virage Navigation System, an Occipital-Cervico-Thoracic (OCT) spinal fixation system featuring the innova...